Lenox Wealth Management’s AbbVie ABBV Stock Holding History

Lenox Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1.03M	Buy	10,495 +309	+3%	+$27.2K	0.31%	57
2020 Q1	$776K	Sell	10,186 -429	-4%	-$36.5K	0.27%	59
2019 Q4	$940K	Sell	10,615 -801	-7%	-$66.5K	0.26%	57
2019 Q3	$864K	Buy	+11,416	New	+$783K	0.25%	62
2019 Q1	–	Sell	-14,500	Closed	-$88K	–	683
2018 Q4	$88K	Buy	+14,500	New	+$1.28M	0.03%	175
2018 Q3	–	Sell	-20	Closed	-$2K	–	640
2018 Q2	$2K	Buy	+20	New	+$1.95K	﹤0.01%	494

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lenox Wealth Management's ABBV Position: Q2 2020 in Review

Lenox Wealth Management increased its AbbVie (ABBV) stake by 3% in Q2 2020, buying an estimated $27.2K and bringing the position to 10,495 shares worth $1.03M. The position accounts for 0.31% of the portfolio, ranked #57.

Lenox Wealth Management first reported a position in ABBV in Q2 2018 and has held it in 6 quarters since. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

Lenox Wealth Management held 10,495 shares of AbbVie worth $1.03M as of Q2 2020.
Lenox Wealth Management bought 309 AbbVie shares in Q2 2020, an estimated $27.2K.
AbbVie made up 0.31% of Lenox Wealth Management's portfolio in Q2 2020, its #57 holding.
Lenox Wealth Management first reported a position in AbbVie in Q2 2018 and has held it in 6 quarters since.
2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.